Abstract
Purpose
To compare color Doppler imaging (CDI) parameters of the superior ophthalmic vein (SOV) in patients with Graves’ orbitopathy (GO) and in normal controls.
Methods
Forty-three GO patients and 14 normal controls underwent CDI of the SOV. Patients had either fibrotic (lipogenic or myogenic) or congestive orbitopathy. The findings for each group were compared.
Results
Fifty-eight orbits with fibrotic orbitopathy, 28 with congestive orbitopathy, and 28 from controls, were studied. In the congestive group, SOV flow was detected in 13, undetectable in 11, and reversed in four orbits; in the fibrotic group, it was present in 41 and undetectable in 17 orbits. In normal controls, SOV flow was detected in 25 and undetectable in three orbits. The differences among the three groups were significant. There was also a significant difference between controls and the congestive GO orbits but not between the fibrotic group and the other two groups. Fibrotic myogenic orbitopathy patients displayed a significantly smaller SOV flow than patients with lipogenic orbitopathy.
Conclusions
SOV was significantly reduced in orbits with congestive GO or with myogenic fibrotic GO, but not in orbits with fibrotic lipogenic orbitopathy. SOV congestion may be a contributing pathogenic factor in both congestive and fibrotic myogenic Graves’ orbitopathy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bartley GB, Gorman CA. Diagnostic criteria for Graves’ ophthalmopathy. Am J Ophthalmol 1995;119:792–795.
Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, et al. Clinical features of Graves’ ophthalmopathy in an incidence cohort. Am J Ophthalmol 1996;121:284–290.
Weetman AP. Thyroid-associated ophthalmopathy. Autoimmunity 1992;12:215–222.
Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R. Clinical criteria for the assessment of disease activity in Graves’ ophthalmopathy: a novel approach. Br J Ophthalmol 1989;73:639–644.
Bartalena L, Pinchera A, Marcocci C. Management of Graves’ ophthalmopathy: reality and perspectives. Endocr Rev 2000;21: 168–199.
Nunery WR. Ophthalmic Graves’ disease: a dual theory of pathogenesis. Ophthalmol Clin North Am 1991;4:73–87.
Rubin PA, Watkins LM, Rumelt S, Sutula FC, Dallow RL. Orbital computed tomographic characteristics of globe subluxation in thyroid orbitopathy. Ophthalmology 1998;105:2061–2064.
Kennerdell JS, Rosenbaum AE, El-Hoshy MH. Apical optic nerve compression of dysthyroid optic neuropathy on computed tomography. Arch Ophthalmol 1981;99:807–809.
Nugent RA, Belkin RI, Neigel JM, et al. Graves orbitopathy: correlation of CT and clinical findings. Radiology 1990;177:675–682.
Hudson HL, Levin L, Feldon SE. Graves exophthalmos unrelated to extraocular muscle enlargement. Superior rectus muscle inflammation may induce venous obstruction. Ophthalmology 1991;98:1495–1499.
Saber E, McDonnell J, Zimmermann KM, Yugar JE, Feldon SE. Extraocular muscle changes in experimental orbital venous stasis: some similarities to Graves’ orbitopathy. Graefes Arch Clin Exp Ophthalmol 1996;234:331–336.
Alp MN, Ozgen A, Can I, Cakar P, Gunalp I. Colour Doppler imaging of the orbital vasculature in Graves’ disease with computed tomographic correlation. Br J Ophthalmol 2000;84:1027–1030.
Nakase Y, Osanai T, Yoshikawa K, Inoue Y. Color Doppler imaging of orbital venous flow in dysthyroid optic neuropathy. Jpn J Ophthalmol 1994;38:80–86.
Somer D, Ozkan SB, Ozdemir H, Atilla S, Soylev MF, Duman S. Colour Doppler imaging of superior ophthalmic vein in thyroid-associated eye disease. Jpn J Ophthalmol 2002;46:341–345.
Benning H, Lieb W, Kahaly G, Grehn F. Color duplex ultrasound findings in patients with endocrine orbitopathy. Ophthalmologe 1994;91:20–25.
Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin Endocrinol (Oxf) 1997;47:9–14.
Trobe JD, Glaser JS, Laflamme P. Dysthyroid optic neuropathy. Clinical profile and rationale for management. Arch Ophthalmol 1978;96:1199–1209.
Yoshikawa K, Higashide T, Inoue T, Inoue Y. Fluorescein angiographic findings in optic discs with dysthyroid optic neuropathy. Orbit 1991;10:89–96.
Erickson SJ, Hendrix LE, Massaro BM, et al. Color Doppler flow imaging of the normal and abnormal orbit. Radiology 1989;173:511–516.
Yanik B, Conkbayir I, Acaroglu G, Hekimoglu B. Graves’ ophthalmopathy: comparison of the Doppler sonography parameters with the clinical activity score. J Clin Ultrasound 2005;33:375–380.
Author information
Authors and Affiliations
About this article
Cite this article
Monteiro, M.L.R., Angotti-Neto, H., Benabou, J.E. et al. Color Doppler imaging of the superior ophthalmic vein in different clinical forms of Graves’ orbitopathy. Jpn J Ophthalmol 52, 483–488 (2008). https://doi.org/10.1007/s10384-008-0594-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-008-0594-y